Division of Psychiatry, UCL, 6th Floor Maple House, 149 Tottenham Court Road, London W1T 7NF, UK.
Division of Psychiatry, UCL, 6th Floor Maple House, 149 Tottenham Court Road, London W1T 7NF, UK.
Schizophr Res. 2022 Aug;246:260-267. doi: 10.1016/j.schres.2022.07.008. Epub 2022 Jul 17.
Severe mental illness (SMI) is associated with poorer physical health, however the relationship between SMI and cancer is complex and previous study findings are inconsistent. Low incidence of cancer in those with SMI has been attributed to premature mortality, though evidence for this is lacking. We aimed to investigate the relationship between SMI and cancer incidence and mortality, and to assess the effect of premature mortality on cancer incidence rates.
In this UK-wide matched cohort study using primary care records we calculated incidence and mortality rates of all-cancer, and bowel, lung, breast or prostate cancer, in patients with SMI, compared to matched patients without SMI. We used competing risks regression to account for mortality from other causes.
69,632 patients had an SMI diagnosis. The rate of all-cancer diagnoses was reduced in those with SMI (Hazard ratio (HR):0·95; 95%CI 0·93-0·98) compared to those without SMI, and particularly in those with schizophrenia (HR:0·82; 95%CI 0·77-0·88) compared to those without SMI. When accounting for the competing risk of premature mortality, incidence remained lower only in patients with schizophrenia. All-cause mortality after cancer was increased in the SMI group, and cancer-specific mortality was increased in those with schizophrenia (hazard ratio: 1.96; 95%CI 1.57-2.44).
Patients with schizophrenia have lower rates of cancer diagnosis but higher all-cause and cancer-specific mortality rates following diagnosis compared to those without SMI. Premature mortality does not explain these differences, suggesting the findings reflect barriers to cancer diagnosis and treatment, which need to be identified and addressed.
严重精神疾病(SMI)与较差的身体健康有关,但 SMI 与癌症之间的关系很复杂,先前的研究结果也不一致。SMI 患者癌症发病率低归因于过早死亡,但缺乏这方面的证据。我们旨在调查 SMI 与癌症发病率和死亡率之间的关系,并评估过早死亡对癌症发病率的影响。
在这项使用初级保健记录的英国范围内的匹配队列研究中,我们计算了 SMI 患者与无 SMI 患者相比所有癌症、肠癌、肺癌、乳腺癌或前列腺癌的发病率和死亡率。我们使用竞争风险回归来考虑其他原因导致的死亡率。
69632 名患者被诊断出患有 SMI。与无 SMI 患者相比,SMI 患者的所有癌症诊断率降低(风险比(HR):0.95;95%置信区间 0.93-0.98),尤其是与无 SMI 患者相比,精神分裂症患者的 HR 降低(HR:0.82;95%置信区间 0.77-0.88)。在考虑到过早死亡的竞争风险后,只有精神分裂症患者的发病率仍然较低。SMI 组癌症后全因死亡率增加,精神分裂症患者的癌症特异性死亡率增加(风险比:1.96;95%置信区间 1.57-2.44)。
与无 SMI 患者相比,精神分裂症患者的癌症诊断率较低,但诊断后全因和癌症特异性死亡率较高。过早死亡并不能解释这些差异,这表明这些发现反映了癌症诊断和治疗的障碍,需要确定和解决。